Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Vnitrni Lekarstvi
|
September 1, 2011
[Haemodialysis - the current practice]
M Nedbálková
Vnitrni Lekarstvi
|
October 18, 2008
[Hypertension in dialysis patients]
M Nedbálková, M Soucek
Vnitrni Lekarstvi
|
September 1, 2011
[Hypertension and cardiovascular complications of chronic renal failure]
M Soucek, V Monhart, M Nedbálková
Vnitrni Lekarstvi
|
August 22, 2000
[Hypertension in hemodialyzed uremic patients]
D Sobotová, A Zharfbin, J Svojanovský, et al.
Vnitrni Lekarstvi
|
April 17, 2010
[More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)]
Z Adam, M Nedbálková, M Krejcí, et al.
Vnitrni Lekarstvi
|
April 17, 2010
[Treatment of AL-amyloidosis--results from one clinic and review of published experience with new agents (bortezomib, thalidomide and lenalidomide) in AL-amyloidosis]
Z Adam, L Pour, M Krejcí, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Vnitrni Lekarstvi
|
September 1, 2011
[Haemodialysis - the current practice]
M Nedbálková
Vnitrni Lekarstvi
|
October 18, 2008
[Hypertension in dialysis patients]
M Nedbálková, M Soucek
Vnitrni Lekarstvi
|
September 1, 2011
[Hypertension and cardiovascular complications of chronic renal failure]
M Soucek, V Monhart, M Nedbálková
Vnitrni Lekarstvi
|
August 22, 2000
[Hypertension in hemodialyzed uremic patients]
D Sobotová, A Zharfbin, J Svojanovský, et al.
Vnitrni Lekarstvi
|
April 17, 2010
[More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)]
Z Adam, M Nedbálková, M Krejcí, et al.
Vnitrni Lekarstvi
|
April 17, 2010
[Treatment of AL-amyloidosis--results from one clinic and review of published experience with new agents (bortezomib, thalidomide and lenalidomide) in AL-amyloidosis]
Z Adam, L Pour, M Krejcí, et al.
Page
of 1